Literature DB >> 17173547

HIV-1 neuropathogenesis: glial mechanisms revealed through substance abuse.

Kurt F Hauser1, Nazira El-Hage, Anne Stiene-Martin, William F Maragos, Avindra Nath, Yuri Persidsky, David J Volsky, Pamela E Knapp.   

Abstract

Neuronal dysfunction and degeneration are ultimately responsible for the neurocognitive impairment and dementia manifest in neuroAIDS. Despite overt neuronal pathology, HIV-1 does not directly infect neurons; rather, neuronal dysfunction or death is largely an indirect consequence of disrupted glial function and the cellular and viral toxins released by infected glia. A role for glia in HIV-1 neuropathogenesis is revealed in experimental and clinical studies examining substance abuse-HIV-1 interactions. Current evidence suggests that glia are direct targets of substance abuse and that glia contribute markedly to the accelerated neurodegeneration seen with substance abuse in HIV-1 infected individuals. Moreover, maladaptive neuroplastic responses to chronic drug abuse might create a latent susceptibility to CNS disorders such as HIV-1. In this review, we consider astroglial and microglial interactions and dysfunction in the pathogenesis of HIV-1 infection and examine how drug actions in glia contribute to neuroAIDS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17173547      PMCID: PMC4305441          DOI: 10.1111/j.1471-4159.2006.04227.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  268 in total

1.  Enhancement of central nervous system pathology in early simian immunodeficiency virus infection by dopaminergic drugs.

Authors:  S Czub; E Koutsilieri; S Sopper; M Czub; C Stahl-Hennig; J G Müller; V Pedersen; W Gsell; J L Heeney; M Gerlach; G Gosztonyi; P Riederer; V ter Meulen
Journal:  Acta Neuropathol       Date:  2001-02       Impact factor: 17.088

Review 2.  Modulation of immune function by morphine: implications for susceptibility to infection.

Authors:  Sabita Roy; Jinghua Wang; Jennifer Kelschenbach; Lisa Koodie; Josephine Martin
Journal:  J Neuroimmune Pharmacol       Date:  2006-03       Impact factor: 4.147

3.  Activation of glycogen synthase kinase 3 beta (GSK-3beta) by platelet activating factor mediates migration and cell death in cerebellar granule neurons.

Authors:  N Tong; J F Sanchez; S B Maggirwar; S H Ramirez; H Guo; S Dewhurst; H A Gelbard
Journal:  Eur J Neurosci       Date:  2001-05       Impact factor: 3.386

Review 4.  HIV infection among intravenous drug users: epidemiology and risk reduction.

Authors:  D C Des Jarlais; S R Friedman
Journal:  AIDS       Date:  1987-07       Impact factor: 4.177

5.  Glutamatergic neurotransmission and protein kinase C play a role in neuron-glia communication during the development of methamphetamine-induced psychological dependence.

Authors:  Mayumi Miyatake; Minoru Narita; Masahiro Shibasaki; Atsushi Nakamura; Tsutomu Suzuki
Journal:  Eur J Neurosci       Date:  2005-09       Impact factor: 3.386

Review 6.  Treatment of opioid dependence and coinfection with HIV and hepatitis C virus in opioid-dependent patients: the importance of drug interactions between opioids and antiretroviral agents.

Authors:  Elinore F McCance-Katz
Journal:  Clin Infect Dis       Date:  2005-07-01       Impact factor: 9.079

7.  Inflammatory changes and breakdown of microvascular integrity in early human immunodeficiency virus dementia.

Authors:  Malcolm J Avison; Avindra Nath; Robin Greene-Avison; Frederick A Schmitt; Rodney A Bales; As'ad Ethisham; Richard N Greenberg; Joseph R Berger
Journal:  J Neurovirol       Date:  2004-08       Impact factor: 2.643

8.  HIV-1 envelope gp120 alters astrocytes in human brain cultures.

Authors:  L Pulliam; D West; N Haigwood; R A Swanson
Journal:  AIDS Res Hum Retroviruses       Date:  1993-05       Impact factor: 2.205

9.  The effect of chronic binge ethanol consumption on the primary stage of SIV infection in rhesus macaques.

Authors:  Gregory J Bagby; David A Stoltz; Ping Zhang; Jay K Kolls; Julie Brown; Rudolf P Bohm; Richard Rockar; Jeanette Purcell; Michael Murphey-Corb; Steve Nelson
Journal:  Alcohol Clin Exp Res       Date:  2003-03       Impact factor: 3.455

10.  Methamphetamine potentiates HIV-1 Tat protein-mediated activation of redox-sensitive pathways in discrete regions of the brain.

Authors:  Govinder Flora; Yong Woo Lee; Avindra Nath; Bernhard Hennig; William Maragos; Michal Toborek
Journal:  Exp Neurol       Date:  2003-01       Impact factor: 5.330

View more
  64 in total

Review 1.  Immunology as it pertains to drugs of abuse, AIDS and the neuroimmune axis: mediators and traffic.

Authors:  Thomas J Rogers
Journal:  J Neuroimmune Pharmacol       Date:  2010-10-19       Impact factor: 4.147

Review 2.  MicroRNAs in opioid pharmacology.

Authors:  Cheol Kyu Hwang; Yadav Wagley; Ping-Yee Law; Li-Na Wei; Horace H Loh
Journal:  J Neuroimmune Pharmacol       Date:  2011-11-09       Impact factor: 4.147

Review 3.  Towards nanomedicines for neuroAIDS.

Authors:  Vidya Sagar; Sudheesh Pilakka-Kanthikeel; Ravi Pottathil; Shailendra K Saxena; Madhavan Nair
Journal:  Rev Med Virol       Date:  2014-01-07       Impact factor: 6.989

4.  Update on mental health issues in patients with HIV infection.

Authors:  Natalia Vlassova; Andrew F Angelino; Glenn J Treisman
Journal:  Curr Infect Dis Rep       Date:  2009-03       Impact factor: 3.725

5.  Critical Role of Beclin1 in HIV Tat and Morphine-Induced Inflammation and Calcium Release in Glial Cells from Autophagy Deficient Mouse.

Authors:  Jessica Lapierre; Myosotys Rodriguez; Chet Raj Ojha; Nazira El-Hage
Journal:  J Neuroimmune Pharmacol       Date:  2018-05-11       Impact factor: 4.147

Review 6.  Cortical consequences of HIV-1 Tat exposure in rats are enhanced by chronic cocaine.

Authors:  Wesley N Wayman; Lihua Chen; Amanda L Persons; T Celeste Napier
Journal:  Curr HIV Res       Date:  2015       Impact factor: 1.581

7.  Callosal degradation in HIV-1 infection predicts hierarchical perception: a DTI study.

Authors:  Eva M Müller-Oehring; Tilman Schulte; Margaret J Rosenbloom; Adolf Pfefferbaum; Edith V Sullivan
Journal:  Neuropsychologia       Date:  2009-12-16       Impact factor: 3.139

8.  CCL5/RANTES gene deletion attenuates opioid-induced increases in glial CCL2/MCP-1 immunoreactivity and activation in HIV-1 Tat-exposed mice.

Authors:  Nazira El-Hage; Annadora J Bruce-Keller; Pamela E Knapp; Kurt F Hauser
Journal:  J Neuroimmune Pharmacol       Date:  2008-09-25       Impact factor: 4.147

9.  Morphine suppresses intracellular interferon-alpha expression in neuronal cells.

Authors:  Qi Wan; Xu Wang; Yan-Jian Wang; Li Song; Shi-Hong Wang; Wen-Zhe Ho
Journal:  J Neuroimmunol       Date:  2008-06-17       Impact factor: 3.478

10.  Involvement of extracellular signal-regulated kinase (ERK1/2)-p53-p21 axis in mediating neural stem/progenitor cell cycle arrest in co-morbid HIV-drug abuse exposure.

Authors:  Shaily Malik; Rinki Saha; Pankaj Seth
Journal:  J Neuroimmune Pharmacol       Date:  2014-01-28       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.